肠系膜上动脉血管内抽吸取栓治疗急性肠系膜缺血:ENDO-SMA2MI注册研究结果
技术成功率为92%,90天死亡率为46%,手术时长超过90分钟和Clavien-Dindo评分大于3为死亡的独立危险因素。
要点
- Penumbra Indigo系统行肠系膜上动脉抽吸取栓技术成功率达92%。
- 90天死亡率为46%,其中19例死亡发生在术后30天内。
- 手术时长超过90分钟和严重术后并发症与死亡风险升高独立相关。
核心结论
- 对急性肠系膜缺血患者使用Penumbra Indigo系统行肠系膜上动脉抽吸取栓可能提供有效的全血管内解决方案,技术成功率高,但死亡率仍高。
研究设计与样本
- 回顾性、观察性、多中心研究,在意大利10个中心开展。
- 研究人群中位年龄80岁(IQR 68-86),52%为男性。
主要发现
- 44例(92%)实现抽吸取栓技术成功。
- 29例(60%)仅接受抽吸取栓,19例(39%)同时接受普通外科手术。
- 31例(64%)需入住ICU,中位ICU停留时间1.5天。
- 28例(58%)发生严重术后并发症(Clavien-Dindo评分>3),平均住院时间10天。
- 90天总死亡率为46%(n=22),其中19例死亡发生在最初30天内,3例发生在30至60天之间。
关键数值与推荐
- 77%的患者在症状发作6小时内到达医院,从急诊接诊至转诊 definitive治疗的中位时间为1小时(IQR 1-5)。
临床怎么用
- 对于急性肠系膜缺血患者,可考虑采用Penumbra Indigo系统行肠系膜上动脉抽吸取栓作为微创治疗选择。
- 应关注手术时长,尽量将手术时间控制在90分钟以内以降低死亡风险。
- 术后需密切监测并积极处理并发症,严重并发症与死亡风险显著相关。
- 尽管技术成功率高,但患者病情重、合并症多,死亡率仍较高,需多学科协作管理。
局限性
- 本研究为回顾性观察性研究,存在选择偏倚和信息偏倚可能。
- 缺乏与非抽吸取栓治疗或其他治疗方式的对照。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/OBJECTIVE: Acute mesenteric ischaemia (AMI) is a multidisciplinary emergency, requiring the involvement of different medical specialties for successful management. Endovascular aspiration thrombectomy (EAT) has entered the field leading to the possibility of treating acute arterial occlusions with a minimally invasive approach. The aim of the study was to provide contemporary data on results after use of EAT in AMI patients. METHODS: The study was a retrospective, observational, multicentre study conducted in 10 Italian centres. Patients with AMI, undergoing EAT of the superior mesenteric artery (SMA) with the Penumbra Indigo system (Penumbra Inc., Alameda, CA, USA) from January 1, 2020 to December 31, 2024 were enrolled. Technical success and mortality were the primary outcomes. Secondary outcomes included perioperative complications and length of stay in the hospital and intensive care unit (ICU). RESULTS: Forty-eight consecutive AMI patients undergoing EAT were enrolled in the study. The median age of the study population was 80 years (interquartile range [IQR] = 68-86), and 52% were male. The median time from emergency acceptance up to referral for definitive treatment was 1 hour (IQR = 1-5), with 77% of patients presenting to the hospital less than 6 hours from onset of symptoms. Overall, 29 patients (60%) received only EAT at presentation, whereas 19 patients (39%) received a combined general surgical procedure at the same time of endovascular intervention. Technical success of EAT was achieved in 44 cases (92%). Thirty-one patients (64%) required ICU stay, with a median duration of 1.5 days. Severe postoperative complications (i.e. Clavien-Dindo scale >3) occurred in 28 patients (58%), and the average duration of hospital stay was 10 days. The overall rate of 90-day mortality was 46% (n = 22); of these, 19 deaths occurred in the first 30 days and 3 additional events occurred between 30 and 60 days after index presentation. On multivariable analysis, a procedure longer than 90 minutes (odds ratio [OR] 6.3; 95% confidence interval [CI], 1.0-37.2; P = .041) and Clavien-Dindo score greater than 3 (OR 19.5; 95% CI, 3.2-115.5; P = <.001) resulted as independent factors for mortality. CONCLUSIONS: The application of the Penumbra Indigo system for EAT of the SMA in AMI cases may provide an effective total endovascular procedure for its solution, providing high technical success rates. However, mortality rates are still high, owing to the severity of illness and comorbid status of patients, with most death events occurring in the first 30 days.Clinical ImpactThe results of this study demonstrate that endovascular aspiration thrombectomy of the superior mesenteric artery for treatment of acute mesenteric ischemia may provide a safe and effective procedure for this condition. However, mortality rates are still high, owing to the severity of illness and comorbid status of patients, with most death events occurring in the first 30 days. Longer procedures and severe postoperative adverse events were also identified to be associated with higher odds of death, thereby highlighting potential bundles for improving care.
引用
- D'Oria M, Lepidi S, Spath P, et al. Endovascular Aspiration Thrombectomy of the Superior Mesenteric Artery for Treatment of Acute Mesenteric Ischemia: Results From the ENDO-SMA2MI Registry. J Endovasc Ther. 2026. PMID: 42664254. doi:10.1177/15266028261479535
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。